Retinal Structure in RPE65-Associated Retinal Dystrophy

被引:29
|
作者
Kumaran, Neruban [1 ,2 ,3 ]
Georgiou, Michalis [1 ,2 ]
Bainbridge, James W. B. [1 ,2 ]
Bertelsen, Mette [4 ]
Larsen, Michael [4 ,5 ]
Blanco-Kelly, Fiona [6 ,7 ]
Ayuso, Carmen [6 ,7 ]
Hoai Viet Tran [8 ]
Munier, Francis L. [8 ]
Kalitzeos, Angelos [1 ,2 ]
Michaelides, Michel [1 ,2 ]
机构
[1] UCL, UCL Inst Ophthalmol, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
[4] Rigshosp, Copenhagen, Denmark
[5] Univ Copenhagen, Copenhagen, Denmark
[6] UAM, IIS FJD, Fdn Jimenez Diaz Univ Hosp, Madrid, Spain
[7] ISCIII, CIBERER, Madrid, Spain
[8] Univ Lausanne, Jules Gonin Eye Hosp, Fdn Asile Aveugles, Lausanne, Switzerland
基金
英国医学研究理事会; 英国惠康基金;
关键词
retinal structure; optical coherence tomography (OCT); autofluorescence; FAF; retina; leber congenital amaurosis; RPE65; LCA; LCA2; clinical trials; endpoints; natural history; LEBER CONGENITAL AMAUROSIS; OPTICAL COHERENCE TOMOGRAPHY; GENE-THERAPY; RPE65; MUTATIONS; FUNDUS AUTOFLUORESCENCE; RETINITIS-PIGMENTOSA; VISUAL FUNCTION; CHILDHOOD; PROGRESSION; EFFICACY;
D O I
10.1167/iovs.61.4.47
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. RPE65-associated retinal dystrophy (RPE65-RD) is an early onset, progressive, severe retinal dystrophy. We sought to characterize the natural history of retinal degeneration in affected individuals. METHODS. We performed cross-sectional and longitudinal quantitative and qualitative assessments of retinal architecture in RPE65-RD using spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging. Twenty-six subjects (mean age, 14.8 years, range, 5-24 years) with RPE65-RD underwent SD-OCT and FAF imaging, of whom 14 subjects were followed up over time. Foveal thickness (FT), outer nuclear layer thickness (ONLT), ellipsoid zone width (EZW), and ellipsoid zone area (EZA) were calculated where possible. These were correlated with age, best corrected visual acuity (BCVA), and central 30 degrees retinal sensitivity (V-30). Intra-observer agreement, test-retest repeatability, and interocular symmetry were also investigated. RESULTS. We identified structural interocular symmetry, the presence of autofluorescence in 46% (12/26) of subjects, and the presence of foveal hypoplasia (associated with significantly worse BCVA) in 50% of subjects. EZW and EZA were measurable in 67% (35/52) and 37% (19/52) of eyes, respectively, with both demonstrating good agreement on repeated measurement. The annual rate of progression using EZW was -300.63 mu m/year, and -1.17 mm(2)/year in EZA. EZW was found to have a statistically significant correlation with BCVA and V-30. CONCLUSIONS. We identified the presence of autofluorescence in half of our subjects, with foveal hypoplasia also noted in half of our cohort. EZW, and to a lesser extent EZA, were robust measures of retinal degeneration and represent valuable metrics to determine the impact of intervention.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy
    Maguire, Albert M.
    Bennett, Jean
    Aleman, Elena M.
    Leroy, Bart P.
    Aleman, Tomas S.
    MOLECULAR THERAPY, 2021, 29 (02) : 442 - 463
  • [2] Gliosis in RPE65-associated inherited retinal degeneration
    Makhlouf, Abed
    Su, Wenqi
    Sun, Shuo
    Lin, Haijiang
    Tian, Bo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [3] Validation of a Vision-Guided Mobility Assessment for RPE65-Associated Retinal Dystrophy
    Kumaran, Neruban
    Ali, Robin R.
    Tyler, Nick A.
    Bainbridge, James W. B.
    Michaelides, Michel
    Rubin, Gary S.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (10): : 1 - 11
  • [4] Prevalence and genetic characteristics of RPE65-associated retinal disease
    Tommiska, J.
    Alastalo, T.
    Kampjarvi, K.
    Guidugli, L.
    Kansakoski, J.
    Wells, K.
    Vastinsalo, H.
    Kaare, M.
    Sarantaus, L.
    Salmenpera, P.
    Gentile, M.
    Bruce, S.
    Sankila, E.
    Koskenvuo, J. W.
    Myllykangas, S.
    Tuupanen, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1242 - 1243
  • [5] Prevalence and genetic characteristics of RPE65-associated retinal disease
    Alastalo, Tero-Pekka
    Kampjarvi, Kati
    Guidugli, Lucia
    Kansakoski, Johanna
    Wells, Kirsty
    Vastinsalo, Hanna
    Sarantaus, Laura
    Salmenpera, Pertteli
    Myllykangas, Samuel
    Sankila, Eeva-Marja Kaarina
    Koskenvuo, Juha
    Tuupanen, Sari
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [6] A morphometric analysis of the retinal arterioles with adaptive optics imaging in RPE65-associated retinal dystrophy after treatment with voretigene neparvovec
    Kortuem, Friederike C.
    Kempf, Melanie
    Merle, David A.
    Kuehlewein, Laura
    Pohl, Lisa
    Reith, Milda
    Jung, Ronja
    Ott, Saskia
    Stingl, Krunoslav
    Stingl, Katarina
    ACTA OPHTHALMOLOGICA, 2024, 102 (03) : e358 - e366
  • [7] RPE65-associated retinal dystrophies: gene therapy preserves vision
    Gerhardt M.-J.
    Michalakis S.
    Rudolph G.
    Priglinger C.
    Priglinger S.G.
    MMW - Fortschritte der Medizin, 2022, 164 (Suppl 4) : 40 - 41
  • [8] Vitreous degeneration in patients treated with subretinal gene therapy for RPE65-associated inherited retinal dystrophy
    van Overdam, K. A.
    van den Born, L. I.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 44 - 45
  • [9] Clinical Features and Natural History in a Cohort of Chinese Patients with RPE65-Associated Inherited Retinal Dystrophy
    Shi, Jie
    Xu, Ke
    Hu, Jian-Ping
    Xie, Yue
    Zhang, Xin
    Zhang, Xiao-Hui
    Jin, Zi-Bing
    Li, Yang
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [10] Relatively preserved retinal function in RPE65-associated retinopathy: a case report
    Mizobuchi, Kei
    Hayashi, Takaaki
    Kameya, Shuhei
    Ohta, Yuri
    Kuribayashi, Kohei
    Shinoda, Kei
    DOCUMENTA OPHTHALMOLOGICA, 2025, : 97 - 104